Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Bright

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacoepidemiology and Drug Safety|May 24, 2024
Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environmentAshish Rai, Judith C Maro, Sarah Dutcher, et al.
Handbook of Experimental Pharmacology|September 2, 2011
Ethical considerations in conducting pediatric researchMichelle Roth-Cline, Jason Gerson, Patricia Bright, et al.
Journal of Veterinary Internal Medicine|September 27, 2002
Endostatin concentrations in healthy dogs and dogs with selected neoplasmsJohn H Rossmeisl, Patricia Bright, Lawrence Tamarkin, et al.
Sexually Transmitted Diseases|October 14, 2004
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infectionsCharles S Morrison, Patricia Bright, Emelita L Wong, et al.
Diabetes Care|February 21, 2020
Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH InsulinsMarie C Bradley, Yoganand Chillarige, Hana Lee, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2024
Validity of inpatient electronic health record-based measures of oxygen-related therapy in the United States: Lessons applicable for studying COVID-19 endpointsCandace C Fuller, Edward Rosen, Ashish Rai, et al.
Drug Safety|April 13, 2026
Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation CenterAnjum Khurshid, David Kendrick, Haritha S Pillai, et al.
Plos One|July 11, 2023
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021Candace C Fuller, Austin Cosgrove, Mayura Shinde, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2024
The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)Rishi J Desai, Keith Marsolo, Joshua Smith, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacoepidemiology and Drug Safety|May 24, 2024
Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environmentAshish Rai, Judith C Maro, Sarah Dutcher, et al.
Handbook of Experimental Pharmacology|September 2, 2011
Ethical considerations in conducting pediatric researchMichelle Roth-Cline, Jason Gerson, Patricia Bright, et al.
Journal of Veterinary Internal Medicine|September 27, 2002
Endostatin concentrations in healthy dogs and dogs with selected neoplasmsJohn H Rossmeisl, Patricia Bright, Lawrence Tamarkin, et al.
Sexually Transmitted Diseases|October 14, 2004
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infectionsCharles S Morrison, Patricia Bright, Emelita L Wong, et al.
Diabetes Care|February 21, 2020
Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH InsulinsMarie C Bradley, Yoganand Chillarige, Hana Lee, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2024
Validity of inpatient electronic health record-based measures of oxygen-related therapy in the United States: Lessons applicable for studying COVID-19 endpointsCandace C Fuller, Edward Rosen, Ashish Rai, et al.
Drug Safety|April 13, 2026
Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation CenterAnjum Khurshid, David Kendrick, Haritha S Pillai, et al.
Plos One|July 11, 2023
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021Candace C Fuller, Austin Cosgrove, Mayura Shinde, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2024
The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)Rishi J Desai, Keith Marsolo, Joshua Smith, et al.
Pageof 2